ロード中...
hERG Potassium Channel Blockade by the HCN Channel Inhibitor Bradycardic Agent Ivabradine
BACKGROUND: Ivabradine is a specific bradycardic agent used in coronary artery disease and heart failure, lowering heart rate through inhibition of sinoatrial nodal HCN‐channels. This study investigated the propensity of ivabradine to interact with KCNH2‐encoded human Ether‐à‐go‐go–Related Gene (hER...
保存先:
| 出版年: | J Am Heart Assoc |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Publishing Ltd
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4579960/ https://ncbi.nlm.nih.gov/pubmed/25911606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.115.001813 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|